Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Topical JAK inhibitors may help treat some skin conditions but need more research.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Combining exosomes with microneedling may improve hair growth in androgenetic alopecia.

Exosome therapy shows promise for hair growth with minimal side effects, but more research is needed.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Traditional and complementary medicine may help with skin conditions, but more high-quality research is needed.

Diuretics can cause serious side effects and should be used carefully.

PRP therapy is effective and safe for skin conditions like wound healing and hair loss.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Fat tissue treatments may help with wound healing and hair growth, but more research with larger groups is needed to be sure.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Combination therapies work better than single treatments for hair loss.